Kolexia
Kwon Theresa Pédiatrie
Kwon Theresa
Pédiatrie
Hôpital Robert-Debré
Paris, France
81 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome néphrotique Défaillance rénale chronique Syndrome hémolytique et urémique Maladies du rein Insuffisance rénale chronique Protéinurie Syndrome de Bartter Poids Infections à Escherichia coli

Collaborateurs

Voir plus
Deschenes Georges
Deschenes Georges
Hôpital Robert-Debré, Paris, France
Hogan Julien
Hogan Julien
Hôpital Robert-Debré, Paris, France
Baudouin Veronique
Baudouin Veronique
Hôpital Robert-Debré, Paris, France
Macher Marie-Alice
Macher Marie-Alice
Hôpital Robert-Debré, Paris, France

Industries

Voir plus
Fresenius Medical Care
1 collaboration(s)
Dernière en 2022
Alexion
1 collaboration(s)
Dernière en 2021
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
MAJESTY: A Phase III Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients With Primary Membranous Nephropathy
Essai Clinique (Roche)   21 mars 2024
POSTERITY: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescent Patients With Active Class III or IV Lupus Nephritis, Including an Evaluation of Open Label Safety and PK in a Cohort of Pediatric Patients (Aged 5 to < 12)
Essai Clinique (Roche)   15 mars 2024
INShore: A Phase III, International, Multicenter, Randomised Open Label Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Patients With Childhood Onset Idiopathic Nephrotic Syndrome
Essai Clinique (Roche)   27 février 2024
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score.
Lupus   05 février 2024
TOTEM: Therapeutic Orientation Test in Thrombotic Microangiopathy
Essai Clinique (CHU Montpellier)   25 janvier 2024
OBIRINS: Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome : a Double-blind Multicenter Randomized Controlled Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   08 novembre 2023
Immunoadsorption as effective treatment of pediatric autoimmune disease-related catatonia, is-it associated to increased cerebro spinal fluid interferon alpha?
Proceedings of the 29th European Paediatric Rheumatology Congress   17 octobre 2023
Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children.
Clinical journal of the American Society of Nephrology : CJASN   06 septembre 2023
Obinutuzumab in Primary FSGS: A Single-center, Phase 2 Open-label Trial Evaluating the Efficacy and Safety of OBINUTUZUMAB in Treatment of Immunosuppression-dependent or Immunosuppression/Treatment-resistant Primary FSGS, or Contraindication/Patient Refusal to Take High Dose Corticosteroids
Essai Clinique (Genentech)   13 juin 2023
Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial.
Journal of the American Society of Nephrology : JASN   12 juin 2023